NYSE: HNGEHinge Health Inc Stock
$44.36-0.50 (-1.11%)
Updated Mar 3, 2026
HNGE Price
$44.36
Fair Value Price
N/A
Market Cap
$3.49B
52 Week Low
$30.08
52 Week High
$62.16
P/E
-5.71x
P/B
19.56x
P/S
4.31x
PEG
N/A
Dividend Yield
N/A
Revenue
$587.86M
Earnings
-$528.26M
Gross Margin
79.6%
Operating Margin
-89.69%
Profit Margin
-72.1%
Debt to Equity
2.05
Operating Cash Flow
$171M
Beta
1.45
Next Earnings
May 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HNGE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
HNGE
Ranked#11 of 45
Ranked#11 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.32 | A | |
| $2.46 | A | |
| $111.90 | A |
Be the first to know about important HNGE news, forecast changes, insider trades & much more!
HNGE News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HNGE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HNGE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HNGE is poor value based on its book value relative to its share price (19.56x), compared to the US Health Information Services industry average (3.3x)
P/B vs Industry Valuation
HNGE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HNGE due diligence checks available for Premium users.
Valuation
HNGE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.71x
Industry
24.45x
Market
37.73x
HNGE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
19.56x
Industry
3.3x
HNGE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HNGE's financial health
Profit margin
Revenue
$170.7M
Net Income
$32.1M
Profit Margin
18.8%
HNGE's Earnings (EBIT) of -$527.26M... subscribe to Premium to read more.
Interest Coverage Financials
HNGE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$744.8M
Liabilities
$366.2M
Debt to equity
2.05
HNGE's short-term assets ($533.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HNGE's short-term assets ($533.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HNGE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$63.9M
Investing
-$37.7M
Financing
-$79.5M
HNGE's operating cash flow ($171.44M)... subscribe to Premium to read more.
Debt Coverage Financials
HNGE vs Health Information Service Stocks
Hinge Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.